CureLab Oncology
Biotechnology Research
Boston, Massachusetts 486 followers
Revolutionary therapies that prolong lives.
About us
CureLab Oncology is a biotechnology company developing new anti-cancer biologics. CureLab Oncology is committed to creating a family of revolutionary therapies for oncology patients in order to help prolong their lives. CureLab Oncology's lead product, Elenagen™, is a plasmid (supercoiled circular DNA) encoding gene p62/SQSTM1. Elenagen™ reverses tumor grade, changes tumor microenvironment, enhances the anti-cancer effects of other therapies (e.g. chemotherapy), mitigates chronic inflammation, and stimulates an immune attack on the tumor. The CureLab Oncology team has completed its international Phase I/IIa Clinical Trials of Elenagen™. The vaccine demonstrated a high degree of safety as well as clinical benefits in a number of patients. Based on these successful results, we initiated Phase II Clinical Trials outside of the United States, and are now preparing Phase II Clinical Trials within the US.
- Website
-
https://www.curelaboncology.com
External link for CureLab Oncology
- Industry
- Biotechnology Research
- Company size
- 2-10 employees
- Headquarters
- Boston, Massachusetts
- Type
- Privately Held
- Founded
- 2000
Locations
-
Primary
Get directions
Boston, Massachusetts 02138, US
Employees at CureLab Oncology
-
Ilya Lapshin
Intellectual Property; Attorney and Principal at IRL Legal Services, LLC; General Counsel at CureLab Oncology, Inc.
-
Yuriy Oreshin
Managing General Partner at X Private Equity
-
Marina Kasaikina, Ph.D.
Senior Consultant at Foresight Science & Technology
-
Kira K.
Supply Chain Management | Project Planning | Time Management | Budgeting | Operations | Logistics | Statistics | Data Analysis | SAP
Updates
-
A good analytical piece about cancer vaccines for non-vaccinologists (the only weаk element of the paper is my interview😊). I think, a pretty comprehensive and objective article. https://lnkd.in/ejeWRnak
Breakthroughs and challenges in therapeutic cancer vaccines: A new era of hope? - Medical Independent
https://www.medicalindependent.ie
-
CureLab Oncology Secures Patent Protection in Canada for Elenagen, Its P62 Plasmid Cancer Therapeutic https://lnkd.in/eVqk2S67
-
Some of the biggest scientific discoveries have been serendipitous events. Today, we announced the publication of CureLab Oncology's most recent clinical study in Frontiers in Oncology. How did the team get lucky and not walk away from an unexpected observation? Read on to learn how they recognized its significance and continued to investigate, leading to a breakthrough discovery. https://lnkd.in/eCttV-7R #biotechnology #cancer #oncology #DNA #vaccine
Elenagen, a novel DNA immunotherapy for the deadliest form of ovarian cancer, delays disease progression
eurekalert.org